We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLP icon
2426
Simulations Plus
SLP
$371M
$100K ﹤0.01%
1,815
+449
+33% +$25.7K
SNDX icon
2427
Syndax Pharmaceuticals
SNDX
$1.82B
$100K ﹤0.01%
5,808
+4,467
+333% +$81.8K
WGO icon
2428
Winnebago Industries
WGO
$900M
$100K ﹤0.01%
1,471
-9,161
-86% -$676K
VTNR
2429
DELISTED
Vertex Energy, Inc
VTNR
$100K ﹤0.01%
7,551
+6,451
+586% +$26.7K
TBIO
2430
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$100K ﹤0.01%
3,643
-5,923
-62% -$116K
AUR icon
2431
Aurora
AUR
$13.6B
$99K ﹤0.01%
+10,055
New +$99.6K
BGC icon
2432
BGC Group
BGC
$4.89B
$99K ﹤0.01%
17,418
-61,688
-78% -$353K
CALM icon
2433
Cal-Maine
CALM
$3.87B
$99K ﹤0.01%
2,742
-291
-10% -$10.9K
INVE icon
2434
Identive
INVE
$61M
$99K ﹤0.01%
5,808
+5,708
+5,708% +$86.2K
KTOS icon
2435
Kratos Defense & Security Solutions
KTOS
$11.8B
$99K ﹤0.01%
3,496
-12,645
-78% -$334K
MGNI icon
2436
Magnite
MGNI
$3.47B
$99K ﹤0.01%
2,904
-22,061
-88% -$747K
TGTX icon
2437
TG Therapeutics
TGTX
$7.52B
$99K ﹤0.01%
2,542
-8,714
-77% -$342K
WSFS icon
2438
WSFS Financial
WSFS
$4.11B
$99K ﹤0.01%
2,123
-2,148
-50% -$109K
QVCGA
2439
DELISTED
QVC Group Inc Series A
QVCGA
$99K ﹤0.01%
152
-554
-78% -$356K
MGI
2440
DELISTED
MoneyGram International, Inc. New
MGI
$99K ﹤0.01%
9,750
+5,111
+110% +$43.1K
BIS icon
2441
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.06M
$98K ﹤0.01%
2,651
-743
-22% -$31.5K
IDV icon
2442
iShares International Select Dividend ETF
IDV
$8.52B
$98K ﹤0.01%
3,019
-14,008
-82% -$462K
MGLN
2443
DELISTED
Magellan Health Services, Inc.
MGLN
$98K ﹤0.01%
1,038
-3,414
-77% -$322K
AKR icon
2444
Acadia Realty Trust
AKR
$2.77B
$97K ﹤0.01%
4,405
-24,926
-85% -$529K
CASH icon
2445
Pathward Financial
CASH
$1.79B
$97K ﹤0.01%
1,906
-1,419
-43% -$70.4K
CCEP icon
2446
Coca-Cola Europacific Partners
CCEP
$46.7B
$97K ﹤0.01%
1,637
-2,812
-63% -$164K
CDC icon
2447
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$741M
$97K ﹤0.01%
1,497
-87
-5% -$5.66K
DBEF icon
2448
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.39B
$97K ﹤0.01%
2,590
-1,410
-35% -$52.7K
DNTH icon
2449
Dianthus Therapeutics
DNTH
$6.08B
$97K ﹤0.01%
624
+194
+45% +$35.6K
FISI icon
2450
Financial Institutions
FISI
$811M
$97K ﹤0.01%
3,241
+2,121
+189% +$66.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.